(Q53511049)

15 May 2018

title

Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats. (English)

1 reference

15 May 2018

1 reference

Caglar Yildiz

1

1 reference

15 May 2018

Turgut Kacan

2

1 reference

15 May 2018

Ozlem Bozoklu Akkar

3

1 reference

15 May 2018

Savas Karakus

4

1 reference

15 May 2018

Selen Baloglu Kacan

5

1 reference

15 May 2018

Hatice Ozer

6

1 reference

15 May 2018

Ali Cetin

7

1 reference

15 May 2018

publication date

11 May 2015

1 reference

15 May 2018

published in

Reproductive Sciences

1 reference

15 May 2018

volume

22

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

1445-1451

1 reference

15 May 2018

Molecular aspects of development and regulation of endometriosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Involvement of the Wnt/β-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Angiogenic factors in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Expression of oct-4 and c-kit antigens in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Angiogenesis and antiangiogenic therapy in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Vascular endothelial growth factor and endometriotic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Sunitinib as an anti-endometriotic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Animal models for anti-angiogenic therapy in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Vascular endothelial growth factor (VEGF) in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Vascular development in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Pathogenesis and pathophysiology of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Mechanistic and therapeutic implications of angiogenesis in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

The C-kit receptor-mediated signal transduction and tumor-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Aberrant expression of apoptosis-related molecules in endometriosis: a possible mechanism underlying the pathogenesis of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719115584448

21 January 2018

Identifiers

DOI

10.1177/1933719115584448

1 reference

15 May 2018

PubMed ID

25963915

1 reference

15 May 2018